GenMark Diagnostics, Inc. (GNMK) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 1000 transactions totaling $31.5M, demonstrating a bearish sentiment with -$29.9M in net insider flow. The most recent transaction on Apr 22, 2021 involved a transaction of 507,198 shares valued at $12.2M.
No significant insider buying has been recorded for GNMK in the recent period.
No significant insider selling has been recorded for GNMK in the recent period.
Based on recent SEC filings, insider sentiment for GNMK is bearish with an Insider Alignment Score of 2/100 and a net flow of -$29.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GenMark Diagnostics, Inc. (GNMK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading GNMK stock, having executed 1000 transactions in the past 90 days. The most active insider is Scott Mendel (Executive), who has made 77 transactions totaling $19.4M.
Get notified when executives and directors at GNMK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 22, 2021 | Mendel Scott | Executive | Tender | 507,198 | $24.05 | $12.2M | Large |
| Apr 22, 2021 | Mendel Scott | Executive | Tender | 115,491 | $24.05 | $2.8M | Large |
| Apr 22, 2021 | Frederick Ek John | Executive | Tender | 232,993 | $24.05 | $5.6M | Large |
| Apr 22, 2021 | Gleeson Michael | Executive | Tender | 421,383 | $24.05 | $10.1M | Large |
| Apr 22, 2021 | Gleeson Michael | Executive | Tender | 30,069 | $24.05 | $723.2K | Large |
| Apr 22, 2021 | John Harkins Michael | Executive | Tender | 144,214 | $24.05 | $3.5M | Large |
| Apr 22, 2021 | Stier Eric | Executive | Tender | 275,974 | $24.05 | $6.6M | Large |
| Apr 22, 2021 | Chohan Abdul | Executive | Tender | 63,750 | $24.05 | $1.5M | Large |
| Apr 22, 2021 | Alexander O'brien Scott | Executive | Tender | 170,879 | $24.05 | $4.1M | Large |
| Apr 22, 2021 | Jensen Tyler | Executive | Tender | 212,249 | $24.05 | $5.1M | Large |
| Apr 22, 2021 | Baer Maderazo Alan | Executive | Tender | 262,180 | $24.05 | $6.3M | Large |
| Apr 22, 2021 | Hollis Winkler Sarah | Executive | Tender | 147,502 | $24.05 | $3.5M | Large |
| Apr 22, 2021 | Shaw Christine | Executive | Tender | 101,324 | $24.05 | $2.4M | Large |
| Apr 22, 2021 | R. Stevenson Wade | Executive | Tender | 50,000 | $24.05 | $1.2M | Large |
| Apr 22, 2021 | C. Oboyle Kevin | Executive | Tender | 131,678 | $24.05 | $3.2M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 21 | $83.9M | 70.9% |
Sale(S) | 717 | $30.7M | 26.0% |
Exercise(M) | 68 | $2.2M | 1.8% |
Purchase(P) | 19 | $779.6K | 0.7% |
Payment(F) | 35 | $723.5K | 0.6% |
Award(A) | 138 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at GenMark Diagnostics, Inc. has increased, with 28 insiders executing 1000 transactions across all time. Total sales of $30.7M significantly outpace purchases of $779.6K, resulting in a net outflow of $29.9M. This selling activity appears largely discretionary, which may warrant closer attention from investors.